| 000 | 01742 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513101404.0 | ||
| 264 | 0 | _c19961105 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0014-4827 | ||
| 024 | 7 |
_a10.1006/excr.1996.0288 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVikhanskaya, F | |
| 245 | 0 | 0 |
_aChanges in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53. _h[electronic resource] |
| 260 |
_bExperimental cell research _cSep 1996 |
||
| 300 |
_a380-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAmsacrine _xpharmacology |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 |
_aCDC2 Protein Kinase _xgenetics |
| 650 | 0 | 4 | _aCyclin B |
| 650 | 0 | 4 | _aCyclin B1 |
| 650 | 0 | 4 | _aCyclin D1 |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinases _xgenetics |
| 650 | 0 | 4 |
_aCyclins _xgenetics |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMutation _xphysiology |
| 650 | 0 | 4 |
_aOncogene Proteins _xgenetics |
| 650 | 0 | 4 | _aOvarian Neoplasms |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aErba, E | |
| 700 | 1 | _aD'Incalci, M | |
| 700 | 1 | _aBroggini, M | |
| 773 | 0 |
_tExperimental cell research _gvol. 227 _gno. 2 _gp. 380-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/excr.1996.0288 _zAvailable from publisher's website |
| 999 |
_c8825791 _d8825791 |
||